March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
There is a well-established and strong link between women, violence and HIV. The Well Project has pulled together a list of resources for those who wish to learn more and take action.
Learn the benefits of starting HIV treatment sooner, and steps to prepare – find a provider, get HIV basics, and have a positive attitude.